Tamer I. Khayal - 06 May 2024 Form 4/A Insider Report for TransMedics Group, Inc. (TMDX)

Signature
By: /s/ Stephen Gordon, Attorney-in-Fact
Issuer symbol
TMDX
Transactions as of
06 May 2024
Net transactions value
$0
Form type
4/A
Filing time
14 May 2024, 18:00:40 UTC
Date Of Original Report
08 May 2024
Previous filing
03 May 2024
Next filing
05 Jun 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TMDX Common Stock 20,843 06 May 2024 Direct
holding TMDX Common Stock 0 06 May 2024 By the Tamer Ibrahim Ahmed Khayal Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Remarks:

This amended Form 4 corrects a clerical error in the Form 4 filed by the Reporting Person on May 8, 2024, which incorrectly reported that 11,051 shares of the Issuer's Common Stock beneficially owned by the Reporting Person were owned by the Tamer Ibrahim Ahmed Khayal Trust. This amended Form 4 corrects the Form 4 to report that 11,051 of the shares of the Issuer's Common Stock reported as being owned by the Tamer Ibrahim Ahmed Khayal Trust were owned directly by the Reporting Person.